Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 328.00
Bid: 325.50
Ask: 330.00
Change: 28.00 (9.33%)
Spread: 4.50 (1.382%)
Open: 304.00
High: 350.00
Low: 303.00
Prev. Close: 300.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale

Tue, 18th May 2021 07:47

(Alliance News) - Stocks in London are set for a higher open on Tuesday following strength in Asia overnight, while the pound built on early gains after a better-than-expected UK jobs print.

The unemployment rate was 4.8% for the three months to March, easing from 4.9% in the three months to February. Consensus, according to FXStreet, had seen the March reading holding steady at 4.9%.

"The latest figures suggest that the jobs market has been broadly stable in recent months, with some early signs of recovery," the ONS said.

This coincides with the easing of lockdown restrictions in the UK. In March, schools in England reopened, followed by the lifting of shutters in April for outdoor hospitality, such as beer gardens, alongside non-essential retail and hairdressers.

The number of payroll employees increased for a fifth consecutive month in April, though does still remain 772,000 below pre-pandemic levels. The largest falls in jobs since February 2020 have been in the hospitality sector, among those aged under 25 years, and those living in London.

Sterling advanced further after the data, quoted at USD1.4183 early Tuesday compared to USD1.4119 at the London equities close on Monday.

Among London listings early Tuesday, Vodafone reported a slip in full-year earnings but held its dividend steady, Phoenix Group confirmed it is in talks to sell its European businesses, and Oxford Biomedica raised guidance on its AstraZeneca vaccine manufacturing deal.

IG says futures indicate the FTSE 100 index of large-caps to open 70.65 points higher, or up 1.0%, at 7,103.50 on Tuesday. The FTSE 100 closed down 10.76 points, or 0.2%, at 7,032.85 on Monday.

The higher start in Europe comes after a subdued session on Wall Street but a brighter mood in Asia overnight.

In the US on Monday, the Dow Jones Industrial Average ended down 0.2%, the S&P 500 down 0.3% and the Nasdaq Composite down 0.4%.

In Asia on Tuesday, however, the Japanese Nikkei 225 index ended up 2.1%. In China, the Shanghai Composite was up 0.1%, while the Hang Seng index in Hong Kong was up 1.3%. The S&P/ASX 200 in Sydney was up 0.6%.

"Asia's performance should set up Europe for a positive start later today. With the worst performers in Asia being the best ones by a country mile today, the lesson here is that an ocean of money still waits on the side-lines to buy equities on material pullbacks, Covid-19 be damned," said Jeffery Halley, a senior market analyst at Oanda.

In early UK company news, telecommunications firm Vodafone posted a "resilient" performance for its recently ended financial year.

Revenue for the financial year to March 31 was EUR43.81 billion, down 2.6% from EUR44.97 billion the year before. Pretax profit jumped to EUR4.40 billion, however, from just EUR795 million the year before, after financing costs fell to EUR1.03 billion from EUR3.55 billion.

Adjusted earnings before interest, tax, depreciation and amortisation fell 3.3% - or declining 1.2% on an organic basis - to EUR14.39 billion from EUR14.88 billion.

Vodafone kept its dividend for the year steady at 9.0 cents.

"I am pleased that we achieved full-year results in line with our guidance and we exited the year with accelerating service revenue growth across the business, with a particularly good performance in our largest market, Germany," said Chief Executive Nick Read.

For the year ahead, Vodafone expects adjusted Ebitda between EUR15.0 billion to EUR15.4 billion, and adjusted free cash flow of at least EUR5.2 billion.

Phoenix Group Holdings, noting press reports, confirmed it is in advanced talks over a potential sale of its European businesses.

"A sale of the European businesses will only be considered if it maximises value for shareholders. Discussions are on-going and there can be no certainty that any transaction will be agreed," the FTSE 100-listed long-term savings and retirement business said.

On Monday, Sky News reported that Phoenix is close to agreeing a GBP550 million deal to sell its European operations.

Oxford Biomedica raised its guidance after pharmaceutical firm AstraZeneca committed to an increase in the number of Covid-19 vaccines needed from the gene and cell therapy company in the second half of 2021.

The two signed an 18-month supply agreement in September under a three-year master supply and development agreement for the large-scale commercial manufacture of the Oxford-AstraZeneca vaccine.

As a result of Astra's commitment, Oxford Biomedica raised its revenue guidance for expected cumulative revenue from Astra by the end of 2021 to in excess of GBP100 million, from in excess of GBP50 million previously, and as such expects "significant growth" in operating Ebitda this year.

In economic data on Tuesday, Japan's economy contracted 1.3% in the three months to March after the government reimposed coronavirus restrictions in major cities as infections surged.

The quarter-on-quarter fall came after the world's third-largest economy grew for two quarters to December, but the expansion was stopped in its tracks by a winter increase in coronavirus cases.

The government imposed new virus states of emergency in January in response, urging people to stay at home and calling for restaurants to close earlier. The economic contraction was largely in line with economists' expectations.

The Japanese yen traded higher after the figures. Against the yen, the dollar slipped to JPY109.09 early Tuesday versus JPY109.20 late Monday.

The euro changed hands at USD1.2183, higher than USD1.2146.

Gold was quoted at USD1,869.76 an ounce early Tuesday, higher than USD1,865.60 on Monday. Brent oil was trading at USD69.68 a barrel, rising from USD69.24 late Monday.

In the economic calendar on Tuesday, besides UK jobs, there is eurozone employment and GDP at 1000 BST and US housing starts at 1330 BST.

Amazon.com is in discussions to acquire the MGM film studio for about USD9 billion, the Financial Times reported Tuesday, citing "people familiar with the matter". MGM's biggest shareholder is hedge fund Anchorage Capital, the newspaper noted. Anchorage started buying the studio's debt in 2010.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
30 Jun 2023 09:50

LONDON BROKER RATINGS: HSBC likes Aviva; Credit Suisse lifts Drax

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
21 Jun 2023 09:38

LONDON BROKER RATINGS: Barclays cuts Rathbones, but raises Grainger

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning on Tuesday:

Read more
16 Jun 2023 15:43

UK shareholder meetings calendar - next 7 days

Monday 19 June 
All ThingsConsidered Group PLCAGM
Blackbird PLCAGM
Finsbury Food Group PLCAGM
Globalworth Real Estate Investments LtdAGM
Marlowe PLCGM re proposed capital reduction
Metals Exploration PLCAGM
Red Rock Resources PLCGM re security conversion into shares for cash
Savannah Resources PLCAGM
Tuesday 20 June 
Acceler8 Ventures PLCAGM
Afentra PLCAGM
Armadale Capital PLCAGM
Bay Capital PLCAGM
Blackrock Smaller Companies Trust PLCAGM
Block Energy PLCAGM
Corero Network Security PLCAGM
Coro Energy PLCAGM
Crimson Tide PLCAGM
Curtis Banks Group PLCAGM
EPE Special Opportunities LtdAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Jersey Oil & Gas PLCAGM
Kore Potash PLCAGM
Lords Group Trading PLCAGM
Mission Group PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Red Capital PLCAGM
Saga PLCAGM
SDX Energy PLCAGM
Skillcast Group PLCAGM
Zegona Communications PLCAGM
Wednesday 21 June 
Argentex Group PLCAGM
Clean Power Hydrogen PLCAGM
Eqtec PLCAGM
Hydrogen Utopia International PLCAGM
HSS Hire Group PLCAGM
Intelligent Ultrasound Group PLCAGM
JD.com IncAGM
RTW Venture Fund LtdAGM
Schroders Capital Global Innovation Trust PLCAGM
Sivota PLCAGM
Numis Corp PLCGM re acquisition by Deuche Bank AG
THG PLCAGM
UK Commercial Property REIT LtdAGM
Thursday 22 June 
Alphawave IP Group PLCAGM
Angling Direct PLCAGM
Anglo Asian Mining PLCAGM
boohoo Group PLCAGM
Card Factory PLCAGM
Ergomed PLCAGM
Futura Medical PLCAGM
Good Energy Group PLCAGM
Grand Vision Media Holdings PLCAGM
Longboat Energy PLCAGM
MaxRets Ventures PLCAGM
Pathfinder Minerals PLCAGM
RBG Holdings PLCAGM
Sanderson Design Group PLCAGM
Team17 Group PLCAGM
Trellus Health PLCAGM
Whitbread PLCAGM
Friday 23 June 
Mears Group PLCAGM
Ocean Harvest Technology Group PLCAGM
Oxford Biomedica PLCAGM
Pelatro PLCAGM
Petrofac LtdAGM
Princess Private Equity Holding LtdAGM
Rathbones Group PLCGM re agreement regarding all-share combination with Invested Wealth & Investment Ltd
Supply@Me Capital PLCGM re open offer warrantholders
Vietnam Enterprise Investments LtdAGM
VPC Specialty Lending Investments PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
24 May 2023 09:31

LONDON BROKER RATINGS: Morgan Stanley raises Deliveroo to 'overweight'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
15 May 2023 11:07

SMALL-CAP WINNERS & LOSERS: PPHE extends Radisson partnership

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

Read more
15 May 2023 10:12

IN BRIEF: Oxford BioMedica launches lentiviral vector system

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Launches its 4th generation lentiviral vector delivery system, TetraVecta. Says the TetraVecta system enhances the development of more effective lentiviral vector-based therapies. Firm says this enables cell and gene therapy companies to overcome previous barriers in therapeutic development.

Read more
25 Apr 2023 11:34

Oxford BioMedica swings to full-year loss amid lower volumes

(Alliance News) - Oxford BioMedica PLC on Tuesday reported a drop in annual revenue and swung to a loss, as a result of lower volumes and higher costs.

Read more
13 Apr 2023 15:47

UK earnings, trading statements calendar - next 7 days

Friday 14 April 
888 Holdings PLCFull Year Results
888 Holdings PLCTrading Statement
AO World PLCTrading Statement
CMC Markets PLCTrading Statement
Devro PLCFull Year Results
Flowtech Fluidpower PLCFull Year Results
Hays PLCTrading Statement
Monday 17 April 
Arecor Therapeutics PLCFull Year Results
Ashmore Group PLCTrading Statement
Diaceutics PLCFull Year Results
PageGroup PLCTrading Statement
Sirius Real Estate LtdTrading Statement
Surface Transforms PLCFull Year Results
Tuesday 18 April 
ASA International Group PLCFull Year Results
Billington Holdings PLCFull Year Results
easyJet PLCTrading Statement
IntegraFin Holdings PLCTrading Statement
LifeSafe Holdings PLCFull Year Results
Moneysupermarket.com Group PLCTrading Statement
Ninety One PLC and LtdTrading Statement
Petra Diamonds LtdTrading Statement
Property Franchise Group PLCFull Year Results
Schroder UK Public Private Trust PLCFull Year Results
THG PLCFull Year Results
THG PLCTrading Statement
Qinetiq Group PLCTrading Statement
Xeros Technology Group PLCFull Year Results
Wednesday 19 April 
Antofagasta PLCTrading Statement
discoverIE Group PLCTrading Statement
Distribution Finance Capital Holdings PLCFull Year Results
Entain PLCQ1 Results
Liontrust Asset Management PLCTrading Statement
Hunting PLCTrading Statement
M Winkworth PLCFull Year Results
Network International Holdings PLCTrading Statement
Quilter PLCTrading Statement
Thursday 20 April 
AJ Bell PLCTrading Statement
Centamin PLCTrading Statement
Dianomi PLCFull Year Results
Dunelm Group PLCQ3 Results
Foxtons Group PLCTrading Statement
GB Group PLCTrading Statement
Hochschild Mining PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Oxford BioMedica PLCFull Year Results
PensionBee Group PLCTrading Statement
Rentokil Initial PLCTrading Statement
Rio Tinto PLCTrading Statement
Segro PLCTrading Statement
WH Smith PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
13 Mar 2023 12:18

SUMMARY: London listings with exposure to Silicon Valley Bank

(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
20 Feb 2023 08:45

IN BRIEF: Oxford BioMedica confirms start date of Mathias as new CEO

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Says Frank Mathias, previously announced as the company's new chief executive officer, will officially join the firm on March 27. Mathias joins Oxford Biomedica from Rentschler Biopharma SE, where he has been CEO since 2016.

Read more
14 Dec 2022 10:25

IN BRIEF: Oxford Biomedica subsidiary signs deals with three US firms

Oxford Biomedica PLC- Oxfordshire, England-based gene and cell therapy group - Says subsidiary Oxford Biomedica Solutions LLC has signed agreements with three unnamed US biotechnology firms. Under the agreements, the subsidiary will provide its full platform offering to support the new partners' pre-clinical gene therapy programmes.

Read more
14 Dec 2022 07:53

LONDON BRIEFING: UK inflation in November cools off record high

(Alliance News) - Stocks in London are set to open lower on Wednesday, ahead of a key interest rate decision by the US Federal Reserve later in the day.

Read more
28 Nov 2022 11:43

Liberum cuts target price for Oxford Biomedica, saying it still lacks sufficient scale

(Sharecast News) - Analysts at Liberum cut their target price for shares Oxford Biomedica arguing that the company's pan-vector offering had yet to reach sufficient scale in order to deliver sustainable profitability.

Read more
22 Nov 2022 10:15

IN BRIEF: Oxford BioMedica appoints Frank Mathias as new CEO

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Appoints Frank Mathias as chief executive officer and board director, effective March 2023.

Read more
22 Nov 2022 09:30

Oxford Biomedica taps Frank Mathias as its new CEO

(Sharecast News) - Gene and cell therapy specialist Oxford Biomedica announced the appointment of Dr Frank Mathias as its new chief executive officer and a board director on Tuesday, effective from March.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.